{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:49:46Z","timestamp":1792763386537,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.gim.2025.101604","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:41:19Z","timestamp":1760139679000},"page":"101604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Reduction of false-positive results with biochemical second-tier testing for newborn screening of Pompe disease"],"prefix":"10.1016","volume":"28","author":[{"given":"Ibrahim T.","family":"Khoja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn S.","family":"Peck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4297-1695","authenticated-orcid":false,"given":"Dimitar K.","family":"Gavrilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly A.","family":"McPheron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin","family":"Oglesbee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8529-6135","authenticated-orcid":false,"given":"Gisele","family":"Bentz Pino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2240-1344","authenticated-orcid":false,"given":"Katie L.","family":"Sapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9356-8669","authenticated-orcid":false,"given":"April L.","family":"Studinski Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8226-615X","authenticated-orcid":false,"given":"Amy L.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Tortorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6298-4138","authenticated-orcid":false,"given":"Dietrich","family":"Matern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9218-6233","authenticated-orcid":false,"given":"Patricia L.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.gim.2025.101604_bib2","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/humu.23878","article-title":"GAA variants and phenotypes among 1,079 patients with Pompe disease: data from the Pompe Registry","volume":"40","author":"Reuser","year":"2019","journal-title":"Hum Mutat"},{"key":"10.1016\/j.gim.2025.101604_bib3","article-title":"An analysis of Pompe newborn screening data: a new prevalence at birth, insight and discussion","volume":"11","author":"Colburn","year":"2023","journal-title":"Front Pediatr"},{"issue":"1","key":"10.1016\/j.gim.2025.101604_bib5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/ijns6010004","article-title":"Newborn screening for Pompe disease in Illinois: experience with 684,290 infants","volume":"6","author":"Burton","year":"2020","journal-title":"Int J Neonatal Screen"},{"issue":"4","key":"10.1016\/j.gim.2025.101604_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/ijns6040089","article-title":"Newborn screening for Pompe disease: Pennsylvania experience","volume":"6","author":"Ficicioglu","year":"2020","journal-title":"Int J Neonatal Screen"},{"issue":"1","key":"10.1016\/j.gim.2025.101604_bib7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/ijns6010002","article-title":"Two-tiered newborn screening with post-analytical tools for Pompe disease and mucopolysaccharidosis type I results in performance improvement and future direction","volume":"6","author":"Hall","year":"2020","journal-title":"Int J Neonatal Screen"},{"issue":"9","key":"10.1016\/j.gim.2025.101604_bib8","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1373\/clinchem.2016.256255","article-title":"Simultaneous testing for 6 lysosomal storage disorders and X-adrenoleukodystrophy in dried blood spots by tandem mass spectrometry","volume":"62","author":"Tortorelli","year":"2016","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.gim.2025.101604_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/ijns6010011","article-title":"Lessons learned from Pompe disease newborn screening and follow-up","volume":"6","author":"Klug","year":"2020","journal-title":"Int J Neonatal Screen"},{"issue":"3","key":"10.1016\/j.gim.2025.101604_bib10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/ijns6030065","article-title":"The impact of post-analytical tools on New York screening for Krabbe disease and Pompe disease","volume":"6","author":"Martin","year":"2020","journal-title":"Int J Neonatal Screen"},{"issue":"8","key":"10.1016\/j.gim.2025.101604_bib11","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/gim.2017.190","article-title":"Moonlighting newborn screening markers: the incidental discovery of a second-tier test for Pompe disease","volume":"20","author":"Tortorelli","year":"2018","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.gim.2025.101604_bib12","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10545-007-0691-y","article-title":"Reduction of the false-positive rate in newborn screening by implementation of MS\/MS-based second-tier tests: the Mayo Clinic experience (2004-2007)","volume":"30","author":"Matern","year":"2007","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"10.1016\/j.gim.2025.101604_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10545-013-9662-7","article-title":"Feasibility of newborn screening for guanidinoacetate methyltransferase (GAMT) deficiency","volume":"37","author":"Pasquali","year":"2014","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"10.1016\/j.gim.2025.101604_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ymgme.2016.05.002","article-title":"A three-tier algorithm for guanidinoacetate methyltransferase (GAMT) deficiency newborn screening","volume":"118","author":"Sinclair","year":"2016","journal-title":"Mol Genet Metab"},{"issue":"8","key":"10.1016\/j.gim.2025.101604_bib15","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/gim.2017.194","article-title":"Precision newborn screening for lysosomal disorders","volume":"20","author":"Minter Baerg","year":"2018","journal-title":"Genet Med"},{"issue":"1-2","key":"10.1016\/j.gim.2025.101604_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107633","article-title":"Disparities in late and lost: pediatricians\u2019 role in following Pompe disease identified by newborn screening","volume":"140","author":"Pillai","year":"2023","journal-title":"Mol Genet Metab"},{"issue":"suppl 1","key":"10.1016\/j.gim.2025.101604_bib17","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1542\/peds.2016-0280D","article-title":"The initial evaluation of patients after positive newborn screening: recommended algorithms leading to a confirmed diagnosis of Pompe disease","volume":"140","author":"Burton","year":"2017","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.gim.2025.101604_bib19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ymgme.2018.08.009","article-title":"Early-onset of symptoms and clinical course of Pompe disease associated with the c.-32-13 T > G variant","volume":"126","author":"Herbert","year":"2019","journal-title":"Mol Genet Metab"},{"issue":"suppl 1","key":"10.1016\/j.gim.2025.101604_bib20","article-title":"P031: late onset Pompe disease diagnoses missed by standard newborn screening procedure: the Indiana experience","volume":"2","author":"Sapp","year":"2024","journal-title":"Genet Med Open"},{"issue":"16-17","key":"10.1016\/j.gim.2025.101604_bib21","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.clinbiochem.2007.07.010","article-title":"Creatine transporter deficiency: prevalence among patients with mental retardation and pitfalls in metabolite screening","volume":"40","author":"Arias","year":"2007","journal-title":"Clin Biochem"},{"issue":"2","key":"10.1016\/j.gim.2025.101604_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/ijns7020024","article-title":"Newborn screening for Krabbe disease-Illinois experience: role of psychosine in diagnosis of the disease","volume":"7","author":"Basheeruddin","year":"2021","journal-title":"Int J Neonatal Screen"},{"issue":"1","key":"10.1016\/j.gim.2025.101604_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/ijns10010010","article-title":"Newborn screening for Krabbe disease: status quo and recommendations for improvements","volume":"10","author":"Matern","year":"2024","journal-title":"Int J Neonatal Screen"},{"issue":"3","key":"10.1016\/j.gim.2025.101604_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107698","article-title":"Newborn screening for the full set of mucopolysaccharidoses in dried blood spots based on first-tier enzymatic assay followed by second-tier analysis of glycosaminoglycans","volume":"140","author":"Herbst","year":"2023","journal-title":"Mol Genet Metab"},{"issue":"1","key":"10.1016\/j.gim.2025.101604_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/ijns8010009","article-title":"Evaluation of two methods for quantification of glycosaminoglycan biomarkers in newborn dried blood spots from patients with severe and attenuated mucopolysaccharidosis Type II","volume":"8","author":"Herbst","year":"2022","journal-title":"Int J Neonatal Screen"},{"issue":"1","key":"10.1016\/j.gim.2025.101604_bib26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/ijns6010010","article-title":"Incorporation of second-tier biomarker testing improves the specificity of newborn screening for mucopolysaccharidosis type I","volume":"6","author":"Peck","year":"2020","journal-title":"Int J Neonatal Screen"},{"issue":"1","key":"10.1016\/j.gim.2025.101604_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2023.101009","article-title":"Two years of newborn screening for Duchenne muscular dystrophy as a part of the statewide Early Check research program in North Carolina","volume":"26","author":"Kucera","year":"2024","journal-title":"Genet Med"},{"issue":"8","key":"10.1016\/j.gim.2025.101604_bib28","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/acn3.51829","article-title":"Newborn screening for Duchenne muscular dystrophy: a two-year pilot study","volume":"10","author":"Tavakoli","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"10.1016\/j.gim.2025.101604_bib29","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2023-062100","article-title":"Evidence and recommendation for guanidinoacetate methyltransferase deficiency newborn screening","volume":"152","author":"Ream","year":"2023","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.gim.2025.101604_bib30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ymgme.2022.01.101","article-title":"Method modification to reduce false positives for newborn screening of guanidinoacetate methyltransferase deficiency","volume":"135","author":"Wojcik","year":"2022","journal-title":"Mol Genet Metab"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360025002515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360025002515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:24:36Z","timestamp":1786663476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360025002515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1098360025002515"],"URL":"https:\/\/doi.org\/10.1016\/j.gim.2025.101604","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction of false-positive results with biochemical second-tier testing for newborn screening of Pompe disease","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gim.2025.101604","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American College of Medical Genetics and Genomics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101604"}}